CAD 0.05
(-10.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -820.85 Thousand | 1.06 Million | -3.43 Million | -186.1 Thousand | 3.88 Million | -58.06 Thousand |
Net Income | -21.69 Million | -17.38 Million | -6.56 Million | -4.42 Million | -3.04 Million | -132.59 Thousand |
Depreciation & Amortization | 4.78 Million | 7.35 Million | 3.97 Million | 1.55 Million | 432.47 Thousand | 156.47 Thousand |
Deferred income taxes | -2.26 Million | -1.78 Million | -426.56 Thousand | 209.91 Thousand | 102.9 Thousand | - |
Stock-based compensation | 204.62 Thousand | 344.14 Thousand | 1.59 Million | 1.77 Million | 425.21 Thousand | 346.54 Thousand |
Change in working capital | 671.62 Thousand | -1.38 Million | -2.02 Million | 136.35 Thousand | 4.86 Million | -391.00 |
Other non-cash items | 24.67 Million | 13.91 Million | 5323.00 | 568.15 Thousand | 1.11 Million | 74.91 Thousand |
Investing Cash Flow | 7.09 Million | -44.6 Thousand | -27.33 Million | -5.6 Million | -6.32 Million | -169.54 Thousand |
Investments in PPE | -17.14 Thousand | -44.6 Thousand | -35.83 Thousand | -68.32 Thousand | -285.27 Thousand | -8224.00 |
Acquisitions | 9.05 Million | - | -27.36 Million | -5.53 Million | -6.45 Million | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 7.11 Million | - | 63 Thousand | -60.61 Thousand | 417.35 Thousand | -161.32 Thousand |
Financing Cash Flow | -9.54 Million | -3.08 Million | 26.17 Million | 9.54 Million | 9.66 Million | 410.35 Thousand |
Debt repayment | -8.15 Million | -1.28 Million | -139.42 Thousand | -5.13 Million | -99.98 Thousand | -54.4 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 743.82 Thousand | 46.95 Thousand | 10.65 Million | 7.56 Million | 3.23 Million | 410.35 Thousand |
Other Financing Activities | -2.01 Million | -1.85 Million | 15.66 Million | 7.11 Million | 6.53 Million | 817.99 Thousand |
Accounts receivables | 1.24 Million | -922.47 Thousand | 371.27 Thousand | -151.13 Thousand | 73.06 Thousand | 45.1 Thousand |
Accounts payables | -1.55 Million | -457.32 Thousand | -1.38 Million | 27.35 Thousand | - | - |
Inventory | 630.13 Thousand | -196.27 Thousand | -443.35 Thousand | 204.98 Thousand | -65.38 Thousand | - |
Other working capital | 355.72 Thousand | 190.55 Thousand | -569.32 Thousand | 55.14 Thousand | 4.92 Million | -391.00 |
Cash at beginning of period | 6.06 Million | 7.76 Million | 12.39 Million | 8.72 Million | 1.63 Million | 423.52 Thousand |
Cash at end of period | 2.72 Million | 5.88 Million | 7.76 Million | 12.39 Million | 8.72 Million | 602.28 Thousand |
Capital Expenditure | -17.14 Thousand | -44.6 Thousand | -35.83 Thousand | -68.32 Thousand | -285.27 Thousand | -8224.00 |
Effect of forex changes on cash | -77.12 Thousand | 182.24 Thousand | -38.42 Thousand | -82.21 Thousand | 35.57 Thousand | -3976.00 |
Net cash flow / Change in cash | -3.34 Million | -1.88 Million | -4.62 Million | 3.67 Million | 7.09 Million | 178.76 Thousand |
Free Cash Flow | -837.99 Thousand | 1.01 Million | -3.46 Million | -254.42 Thousand | 3.6 Million | -66.28 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -663.36 Thousand | 9442.00 | -21.69 Million | -17.52 Million | 349.49 Thousand | -1.95 Million |
Depreciation & Amortization | 59.49 Thousand | 192.38 Thousand | 4.78 Million | 1.51 Million | 886.17 Thousand | 1.22 Million |
Deferred income taxes | 36.1 Thousand | -170.48 Thousand | -2.26 Million | -941.23 Thousand | -589.46 Thousand | -487.9 Thousand |
Stock-based compensation | 29.36 Thousand | 25.27 Thousand | 204.62 Thousand | 60.89 Thousand | 28.16 Thousand | 38.35 Thousand |
Change in working capital | 230.15 Thousand | -567.2 Thousand | 671.62 Thousand | 872.17 Thousand | -682.5 Thousand | 424.03 Thousand |
Other non-cash items | -190.4 Thousand | 511.4 Thousand | 24.67 Million | 17.92 Million | -521.66 Thousand | 1.54 Million |
Investing Cash Flow | 251.04 Thousand | 10.74 Million | 7.09 Million | 23.78 Thousand | 931.34 Thousand | 7.96 Million |
Investments in PPE | -2.00 | - | -17.14 Thousand | -850.00 | -1990.00 | -1648.00 |
Acquisitions | 251.04 Thousand | 10.93 Million | 9.05 Million | 24.63 Thousand | 933.33 Thousand | 9.9 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 251.04 Thousand | -182.01 Thousand | 7.11 Million | 24.63 Thousand | 933.33 Thousand | -1.93 Million |
Financing Cash Flow | -56.92 Thousand | -10.09 Million | -9.54 Million | -146.94 Thousand | -985.04 Thousand | -8.7 Million |
Debt repayment | -16.92 Thousand | -10.02 Million | -8.15 Million | -29.17 Thousand | -678.99 Thousand | -7.27 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 743.82 Thousand | 942.00 | 722.88 Thousand | 20 Thousand |
Other Financing Activities | -40 Thousand | -49.53 Thousand | -2.01 Million | -118.71 Thousand | -1.02 Million | -1.44 Million |
Accounts receivables | 139.4 Thousand | 19.26 Thousand | 1.24 Million | -274.44 Thousand | -86.56 Thousand | 757.31 Thousand |
Accounts payables | -94.78 Thousand | -495.35 Thousand | -1.55 Million | 1.22 Million | -773.66 Thousand | -762.41 Thousand |
Inventory | 123.23 Thousand | 56.01 Thousand | 630.13 Thousand | -269.74 Thousand | 88.53 Thousand | -110.35 Thousand |
Other working capital | 62.3 Thousand | -147.12 Thousand | 355.72 Thousand | 192.77 Thousand | 89.19 Thousand | 539.48 Thousand |
Cash at beginning of period | 2.75 Million | 2.72 Million | 6.06 Million | 2.44 Million | 2.81 Million | 2.84 Million |
Cash at end of period | 2.44 Million | 2.75 Million | 2.72 Million | 2.72 Million | 2.25 Million | 2.81 Million |
Capital Expenditure | -2.00 | - | -17.14 Thousand | -850.00 | -1990.00 | -1648.00 |
Effect of forex changes on cash | 7878.00 | 31.28 Thousand | -77.12 Thousand | -27.88 Thousand | 24.45 Thousand | -71.37 Thousand |
Net cash flow / Change in cash | -313.25 Thousand | 30.64 Thousand | -3.34 Million | 284.11 Thousand | -559.04 Thousand | -36.29 Thousand |
Free Cash Flow | -515.26 Thousand | -658.82 Thousand | -837.99 Thousand | 434.3 Thousand | -531.78 Thousand | 779.4 Thousand |
REMEDY
036630
BIOIF
192080
PLTK
ALTRI